Francis Hunter, PhD Mesopharm Therapeutics, Inc..

Francis Hunter, PhD

Mesopharm Therapeutics, Inc.

Entrepreneurship is a Team Sport

Co-Founder, CEO BTech, PhD

Liggins Institute Business Development

Plant & Food Founder & CEO

Lab Trader NZ Fulbright Scholarship

MBA Stanford GSB

Breast Cancer Startup Challenge

200 teams 83 universities 4,356 years of experienceVenture capitalists, seasoned entrepreneurs, clinicians

scientists, consultants, life science executives

Breast Cancer Startup Challenge

Commercial development plan 130 pages Product and R&D strategy Commercialisation and regulatory strategies Market, IP and competition analyses Financial models Operational strategy

Live pitch

Online elevator pitch

Breast Cancer Startup Challenge

Breast Cancer Startup Challenge

Breast Cancer Startup Challenge

Mesopharm Therapeutics, Inc. (DE C-Corp)

Mesopharm Therapeutics NZ Limited

Armed Antibody Therapeutic

Monoclonal antibody

Highly cytotoxic drugAlpha particle (Actinium-225)

ADC IND Submissions to the FDA

KadcylaPeak sales US $2–5BGenentech/RocheAdcetris

Peak sales US $1B+Seattle Genetics

Networking Matters

ONESTART Accelerator

Francis Hunter Graeme Fielder

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2015

2003

B.Tech

Ph.D.

MBA (Stanford)

Plant & Food BD

Industry Liaison

Industry Liaison

CEO

Chair

Research Lead

CEO

Chair

Ph.D.

Hons.

B.Sc.

Challenges Lead

Education Lead

Participant

Participant

Judge

Research Fellow

Technical & Entrepreneurial Training

Experienced Advisors Are Essential

Thorsten Melcher, PhDSenior DirectorJohnson & Johnson Innovation

Thorsten Melcher, MD PhDFounder & CEOLa Jolla Pharmaceuticals

Jeanette Wood, PhDCSOGenkyotex

Jilly Evans, PhDCo-Founder & CSOPharmAkea

Leon Chen, PhD MBAPartnerOrbiMed

Michael Kolodziej, MDNational Oncology DirectorAetna

Tom John, MBBS PhDHead of Thoracic OncologyAustin Hospital

NZ, US, AusR&D

Best-in-classtherapeutics

Management& advisory

strength

Enter the Spark Challenge!

In-Licensing Technology

Leverage

Starting Up by Licensing

ibridgenetwork.org – 18,000 patents 15,000 new patents filed by US universities

in FY2013

Starting Up by Licensing: Playbook

Define a PROBLEM (=MARKET) RESEARCH the problem and possible solutions Identify technology PATENTS Choose your top 5 and become a

TERRIBLE EXPERT Approach the inventors and licensing

institution Select your best tech: Impact and maturity Build your TEAM, then LICENSE

francis@mesopharm.co

@TumourKiller